Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Arming An Anti-CD38, Myeloma-Targeting Antibody With An Attenuated IFNα Provides >10,000-Fold Enhanced Tumor-Specific Activity Compared To Native IFNα

Sarah L. Pogue, PH.D., Tetsuya Taura, Ph.D., Mingying Bi, MA, Glen E. Mikesell, Yong Yun, Angela Sho, Eric Sanchez, Haiming Chen, MD., Ph.D, James R. Berenson, MD, David S. Wilson, Ph.D.

Blood (2013) 122 (21): 1956.

https://doi.org/10.1182/blood.V122.21.1956.1956

Published: 2013

Journal Articles

Carfilzomib Platform Study Using The LAGκ-1A Multiple Myeloma Xenograft Model

Eric Sanchez, Mingjie Li, Suzie Vardanyan, Jillian Gottlieb, Kevin Delijani, Joseph Ben-Zvi, Mitchell Song, Ran Halleluyan, Cathy S Wang, Haiming Chen, MD., Ph.D, James R. Berenson, MD

Blood (2013) 122 (21): 4452.

https://doi.org/10.1182/blood.V122.21.4452.4452

Published: 2013

Journal Articles

Higher TRAF6 and Fbxo 3 Expression Is With Progressive Multiple Myeloma and Blockage Of TRAF6 Inhibits Tumor Growth and Bone Resorption

Mingjie Li, Suzie Vardanyan, Jillian Gottlieb, Cathy Wang, Kevin Delijani, Ran Halleluyan, Joseph Ben-Zvi, Mitchell Song, Eric Sanchez, Benjamin Bonavida, Ph.D, Haiming Chen, MD., Ph.D, James R. Berenson, MD

Blood (2013) 122 (21): 5362.

https://doi.org/10.1182/blood.V122.21.5362.5362

Published: 2013

Journal Articles

Increased M2 Macrophages and Higher Levels Of The Tribble Family Member Trib1 In Monocytes Are Associated With Progressive Disease In Multiple Myeloma (MM) Patients

Haiming Chen, MD., Ph.D, Mingjie Li, Suzie Vardanyan, Jillian Gottlieb, Cathy Wang, Kevin Delijani, Joseph Ben-Zvi, Mitchell Song, Ran Halleluyan, Eric Sanchez, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2013) 122 (21): 3127.

https://doi.org/10.1182/blood.V122.21.3127.3127

Published: 2013

Journal Articles

Anti-Myeloma Effects of Carfilzomib with Cyclophosphamide (CY) or Bendamustine (Ben).

Eric Sanchez, Mingjie Li, Cathy Wang, Haiming Chen, MD., Ph.D, James R. Berenson, MD

Blood (2012) 120 (21): 2952.

https://doi.org/10.1182/blood.V120.21.2952.2952

Published: 2012

Journal Articles

Decreased LIMD1 Gene Expression Is Associated with HIF-1α Over-Expression and Angiogenesis in Multiple Myeloma

Haiming Chen, MD., Ph.D, Jennifer Li, Kevin Delijani, Danielle Rauch, Kevin DeCorso, Andrew Prajogi, Cathy S Wang, Eric Sanchez, Benjamin Bonavida, Ph.D, James R. Berenson, MD

Blood (2012) 120 (21): 1829.

https://doi.org/10.1182/blood.V120.21.1829.1829

Published: 2012

Journal Articles

Phosphoinositide 3'-Kinase (PI3K) Delta Inhibitor, GS-9820, Enhances Anti-Tumor Efficacy When Combined with Conventional Chemotherapeutic Agents in Primary Samples and Human Tumor Xenograft Model of Multiple Myeloma

Eric Sanchez, Mingjie Li, Cathy Wang, Haiming Chen, MD., Ph.D, Dave M. Johnson, Brian J. Lannutti, PhD, James R. Berenson, MD

Blood (2012) 120 (21): 4017.

https://doi.org/10.1182/blood.V120.21.4017.4017

Published: 2012

Journal Articles

Serum Levels of B-Cell Maturation Antigen Are Elevated in Multiple Myeloma Patients and Correlate with Disease Status and Overall Survival

Eric Sanchez, Mingjie Li, Alex Kitto, Jennifer Li, Cathy S Wang, Danielle Rauch, Kevin Delijani, Kevin DeCorso, Andrew Prajogi, Haiming Chen, MD., Ph.D, James R. Berenson, MD

Blood (2012) 120 (21): 4026.

https://doi.org/10.1182/blood.V120.21.4026.4026

Published: 2012

Journal Articles

Anti-Myeloma Effects of the Janus Kinase 2 (JAK2) Inhibitor SAR503 Alone and in Combination Treatment

Haiming Chen, MD., Ph.D, Mingjie Li, Jennifer Li, Kevin Delijani, Danielle Rauch, Kevin DeCorso, Andrew Prajogi, Cathy S Wang, Eric Sanchez, Benjamin Bonavida, Ph.D, James R. Berenson, MD

Blood (2012) 120 (21): 4986.

https://doi.org/10.1182/blood.V120.21.4986.4986

Published: 2012

Journal Articles

Identification of Novel Receptors on Myeloma Cells and Monocytes That Contribute to Myeloma Tumor Proliferation and Angiogenesis.

Melinda S. Gordon, PhD, Hee Jin Lee, BS, Richard A. Campbell, BS, Haiming Chen, MD, Ph.D, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2005) 106 (11): 2507.

https://doi.org/10.1182/blood.V106.11.2507.2507

Published: 2005

NARROW

Arming An Anti-CD38, Myeloma-Targeting Antibody With An Attenuated IFNα Provides >10,000-Fold Enhanced Tumor-Specific Activity Compared To Native IFNα

Carfilzomib Platform Study Using The LAGκ-1A Multiple Myeloma Xenograft Model

Higher TRAF6 and Fbxo 3 Expression Is With Progressive Multiple Myeloma and Blockage Of TRAF6 Inhibits Tumor Growth and Bone Resorption

Increased M2 Macrophages and Higher Levels Of The Tribble Family Member Trib1 In Monocytes Are Associated With Progressive Disease In Multiple Myeloma (MM) Patients

Anti-Myeloma Effects of Carfilzomib with Cyclophosphamide (CY) or Bendamustine (Ben).

Decreased LIMD1 Gene Expression Is Associated with HIF-1α Over-Expression and Angiogenesis in Multiple Myeloma

Phosphoinositide 3'-Kinase (PI3K) Delta Inhibitor, GS-9820, Enhances Anti-Tumor Efficacy When Combined with Conventional Chemotherapeutic Agents in Primary Samples and Human Tumor Xenograft Model of Multiple Myeloma

Serum Levels of B-Cell Maturation Antigen Are Elevated in Multiple Myeloma Patients and Correlate with Disease Status and Overall Survival

Anti-Myeloma Effects of the Janus Kinase 2 (JAK2) Inhibitor SAR503 Alone and in Combination Treatment

Identification of Novel Receptors on Myeloma Cells and Monocytes That Contribute to Myeloma Tumor Proliferation and Angiogenesis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only